Cohen Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Hold
2,090
0.04% 141
2026
Q1
$291K Hold
2,090
0.05% 138
2025
Q4
$257K Hold
2,090
0.04% 140
2025
Q3
$232K Hold
2,090
0.04% 140
2025
Q2
$232K Hold
2,090
0.04% 144
2025
Q1
$234K Buy
+2,090
New +$216K 0.04% 141
2024
Q4
Sell
-2,390
Closed -$200K 156
2024
Q3
$200K Buy
+2,390
New +$182K 0.03% 152
2023
Q1
Sell
-2,390
Closed -$205K 137
2022
Q4
$205K Buy
+2,390
New +$189K 0.04% 135
2022
Q3
Sell
-3,890
Closed -$240K 137
2022
Q2
$240K Hold
3,890
0.05% 135
2022
Q1
$231K Hold
3,890
0.04% 141
2021
Q4
$282K Hold
3,890
0.05% 136
2021
Q3
$272K Hold
3,890
0.05% 138
2021
Q2
$268K Hold
3,890
0.05% 135
2021
Q1
$251K Hold
3,890
0.05% 132
2020
Q4
$227K Hold
3,890
0.05% 133
2020
Q3
$246K Hold
3,890
0.06% 128
2020
Q2
$299K Hold
3,890
0.07% 119
2020
Q1
$291K Buy
3,890
+290
+8% +$20K 0.09% 111
2019
Q4
$234K Hold
3,600
0.05% 127
2019
Q3
$228K Buy
3,600
+500
+16% +$32.7K 0.05% 127
2019
Q2
$209K Hold
3,100
0.05% 125
2019
Q1
$202K Hold
3,100
0.05% 125
2018
Q4
$194K Hold
3,100
0.05% 124
2018
Q3
$239K Hold
3,100
0.05% 131
2018
Q2
$220K Buy
+3,100
New +$219K 0.05% 134
2017
Q2
Sell
-2,310
Closed -$157K 184
2017
Q1
$157K Buy
+2,310
New +$162K 0.04% 134
2015
Q3
Sell
-1,400
Closed -$164K 128
2015
Q2
$164K Buy
+1,400
New +$153K 0.04% 129

Other funds holding GILD

Cohen Capital Management's GILD Position: Q2 2026 in Review

Cohen Capital Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,090 shares worth $264K. The position accounts for 0.04% of the portfolio, ranked #141.

Cohen Capital Management first reported a position in GILD in Q2 2015 and has held it in 27 quarters since. The position peaked at $299K in Q2 2020. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cohen Capital Management held 2,090 shares of Gilead Sciences worth $264K as of Q2 2026.
  • Cohen Capital Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.04% of Cohen Capital Management's portfolio in Q2 2026, its #141 holding.
  • Cohen Capital Management first reported a position in Gilead Sciences in Q2 2015 and has held it in 27 quarters since.
  • Cohen Capital Management's Gilead Sciences position peaked at $299K in Q2 2020.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cohen Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.